Teriflunomide shows consistent clinical efficacy on severe relapses across two phase 3 trials in patients with relapsing forms of multiple sclerosis, temso and tower

Authors
Category Primary study
JournalNeurology
Year 2015
This article has no abstract
Epistemonikos ID: c78e81924d0921f3e81f9268f3ff99d2132587c8
First added on: Feb 07, 2025